
    
      The drug being tested in this survey is called vonoprazan. Vonoprazan is being tested to
      treat patients who have reflux esophagitis.

      This survey will look at the safety and effectiveness of long-term administration of
      vonoprazan tablets when used as maintenance therapy for reflux esophagitis in routine
      clinical settings. The survey will enroll approximately 1000 participants.

      - Vonoprazan 10 mg or 20 mg

      This multi-center observational trial will be conducted in Japan.
    
  